USD 5.27
(3.33%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 31.46 Million USD | -26.77% |
2022 | 42.96 Million USD | 417.8% |
2021 | 8.29 Million USD | 35.11% |
2020 | 6.14 Million USD | 18.03% |
2019 | 5.2 Million USD | 64.65% |
2018 | 3.16 Million USD | 85.99% |
2017 | 1.69 Million USD | -5.37% |
2016 | 1.79 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 23.37 Million USD | 0.0% |
2024 Q1 | 23.37 Million USD | -25.71% |
2023 FY | 31.46 Million USD | -26.77% |
2023 Q3 | 31.46 Million USD | -23.68% |
2023 Q4 | 31.46 Million USD | 0.0% |
2023 Q2 | 41.22 Million USD | 0.0% |
2023 Q1 | 41.22 Million USD | -4.05% |
2022 Q2 | 41.12 Million USD | 0.0% |
2022 Q4 | 42.96 Million USD | 0.0% |
2022 Q3 | 42.96 Million USD | 4.47% |
2021 Q2 | 9.7 Million USD | 0.0% |
2021 Q4 | 8.29 Million USD | 0.0% |
2020 Q4 | 6.14 Million USD | 0.0% |
2020 Q2 | 4.46 Million USD | 0.0% |
2019 Q4 | 5.2 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Accuray Incorporated | 423.54 Million USD | 92.572% |
Envoy Medical, Inc. | 9.4 Million USD | -234.62% |
Delcath Systems, Inc. | 22.83 Million USD | -37.769% |